PPAR gamma activating agent

This PPAR gamma activating agent is characterized by containing a butenolide compound represented by expression (1), or a pharmaceutically permissible salt thereof. [In formula expression (1), R1 is a hydrogen atom, a phosphate group, a fatty acid group, an alkyl group of 1-4 carbon atoms optionally...

Full description

Saved in:
Bibliographic Details
Main Authors YAMASHITA YUSUKE, AN JIYEONG, YAMATSU ATSUSHI, TSUJINO YOSHIO, MASUTANI BUMBU, HARADA SEIYU
Format Patent
LanguageChinese
English
Published 22.02.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This PPAR gamma activating agent is characterized by containing a butenolide compound represented by expression (1), or a pharmaceutically permissible salt thereof. [In formula expression (1), R1 is a hydrogen atom, a phosphate group, a fatty acid group, an alkyl group of 1-4 carbon atoms optionally and having a substituent, or a sugar residue optionally having a substituent, and R2 is a phenyl group, a methyl phenyl group, a dimethyl phenyl group, an ethylphenyl group, a benzyl group, a methylbenzyl group, a dimethylbenzyl group, an ethyl benzyl group, a phenethyl group, a methylphenethyl group, a dimethyl phenethyl group or an ethyl phenethyl group.] 种PPARγ活化剂,其特征在于,含有式(1)所表示的丁烯羟酸内酯化合物或其药学上容许的盐。式(1)中,R表示氢原子、磷酸基、脂肪酸基、也可以具有取代基的碳原子数为1~4的烷基或也可以具有取代基的糖残基,R表示苯基、甲基苯基、二甲基苯基、乙基苯基、苄基、甲基苄基、二甲基苄基、乙基苄基、苯乙基、甲基苯乙基、二甲基苯乙基或乙基苯乙基。
Bibliography:Application Number: CN201580022943